Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis.

Steven M. Zeitels*, Gerardo Lopez-Guerra, James A. Burns, Matthew Lutch, Aaron M. Friedman, Robert E. Hillman

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis.'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry